Prostaglandin E2 receptor type 2-selective agonist prevents the degeneration of articular cartilage in rabbit knees with traumatic instability

Arthritis Research and Therapy

Volumn 13, Issue 5, 2011, Pages

  Mitsui, Hiroto ^a,c   Aoyama, Tomoki ^a,d   Furu, Moritoshi ^a,b   Ito, Kinya ^a,c   Jin, Yonghui ^a   Maruyama, Takayuki ^e   Kanaji, Toshiya ^e   Fujimura, Shinsei ^e   Sugihara, Hikaru ^e   Nishiura, Akio ^e   Otsuka, Takanobu ^c   Nakamura, Takashi ^b   Toguchida, Junya ^a,b,f  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e ONO PHARMACEUTICAL CO   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

ACLMT; EP2; ONO 8815Ly; Osteoarthritis; Prostaglandin E2

Indexed keywords

COLLAGENASE 3; GELATIN; ONO 8815LY; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; MICROSPHERE; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; FEMALE; KNEE; KNEE INJURY; KNEE MENISCUS; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; INJURY; PATHOLOGY; PHYSIOLOGY; RABBIT; RANDOMIZATION;

ANIMALS; CARTILAGE, ARTICULAR; CELLS, CULTURED; FEMALE; KNEE INJURIES; MICROSPHERES; PROSTAGLANDINS; RABBITS; RANDOM ALLOCATION; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE;

EID: 80052669272     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3460     Document Type: Article

References (39)

1. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001, 60:91-97. 10.1136/ard.60.2.91, 1753462, 11156538.
2. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 2004, 427 Suppl:S6-15.
3. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004, 427 Suppl:S27-36.
4. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007, 213:626-634. 10.1002/jcp.21258, 17786965.
5. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545. 10.1172/JCI119316, 507973, 9119997.
6. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T, Poole AR, Babij P, DeGennaro LJ. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001, 107:35-44. 10.1172/JCI10564, 198546, 11134178.
7. Hu Y, Xiang JS, DiGrandi MJ, Du X, Ipek M, Laakso LM, Li J, Li W, Rush TS, Schmid J, Skotnicki JS, Tam S, Thomason JR, Wang Q, Levin JI. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorg Med Chem 2005, 13:6629-6644. 10.1016/j.bmc.2005.07.076, 16216515.
8. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
9. Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 2003, 15:623-627. 10.1097/00002281-200309000-00017, 12960491.
10. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003, 33:155-167. 10.1016/S0049-0172(03)00134-3, 14671726.
11. Bunning RA, Russell RG. The effect of tumor necrosis factor alpha and gamma-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes. Arthritis Rheum 1989, 32:780-784. 10.1002/anr.1780320618, 2500131.
12. Lippiello L, Yamamoto K, Robinson D, Mankin HJ. Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Arthritis Rheum 1978, 21:909-917. 10.1002/art.1780210807, 737014.
13. Li X, Ellman M, Muddasani P, Wang JH, Cs-Szabo G, van Wijnen AJ, Im HJ. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum 2009, 60:513-523. 10.1002/art.24258, 2659545, 19180509.
14. Riquet FB, Lai WF, Birkhead JR, Suen LF, Karsenty G, Goldring MB. Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 2000, 6:705-719. 1949972, 11055589.
15. Miyamoto M, Ito H, Mukai S, Kobayashi T, Yamamoto H, Kobayashi M, Maruyama T, Akiyama H, Nakamura T. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage 2003, 11:644-652. 10.1016/S1063-4584(03)00118-3, 12954235.
16. Di Battista JA, Dore S, Morin N, He Y, Pelletier JP, Martel-Pelletier J. Prostaglandin E2 stimulates insulin-like growth factor binding protein-4 expression and synthesis in cultured human articular chondrocytes: possible mediation by Ca(++)-calmodulin regulated processes. J Cell Biochem 1997, 65:408-419. 10.1002/(SICI)1097-4644(19970601)65:3<408::AID-JCB10>3.0.CO;2-B, 9138096.
17. Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, Hahn TJ. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 1996, 137:2208-2216. 10.1210/en.137.6.2208, 8641167.
18. Aoyama T, Liang B, Okamoto T, Matsusaki T, Nishijo K, Ishibe T, Yasura K, Nagayama S, Nakayama T, Nakamura T, Toguchida J. PGE2 signal through EP2 promotes the growth of articular chondrocytes. J Bone Miner Res 2005, 20:377-389.
19. Otsuka S, Aoyama T, Furu M, Ito K, Jin Y, Nasu A, Fukiage K, Kohno Y, Maruyama T, Kanaji T, Nishiura A, Sugihara H, Fujimura S, Otsuka T, Nakamura T, Toguchida J. PGE2 signal via EP2 receptors evoked by a selective agonist enhances regeneration of injured articular cartilage. Osteoarthritis Cartilage 2009, 17:529-538. 10.1016/j.joca.2008.09.003, 18922704.
20. Tani K, Naganawa A, Ishida A, Egashira H, Sagawa K, Harada H, Ogawa M, Maruyama T, Ohuchida S, Nakai H, Kondo K, Toda M. Design and synthesis of a highly selective EP2-receptor agonist. Bioorg Med Chem Lett 2001, 11:2025-2028. 10.1016/S0960-894X(01)00359-6, 11454472.
21. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev 1997, 28:43-70. 10.1016/S0169-409X(97)00050-1, 10837564.
22. Park SR, Park SH, Jang KW, Cho HS, Cui JH, An HJ, Choi MJ, Chung SI, Min BH. The effect of sonication on simulated osteoarthritis. Part II: alleviation of osteoarthritis pathogenesis by 1 MHz ultrasound with simultaneous hyaluronate injection. Ultrasound Med Biol 2005, 31:1559-1566. 10.1016/j.ultrasmedbio.2005.07.001, 16286033.
23. Sakakibara Y, Miura T, Iwata H, Kikuchi T, Yamaguchi T, Yoshimi T, Itoh H. Effect of high-molecular-weight sodium hyaluronate on immobilized rabbit knee. Clin Orthop Relat Res 1994, 282-292.
24. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53:523-537.
25. Noguchi K, Maeda M, Ruwanpura SM, Ishikawa I. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells. Oral Dis 2005, 11:157-162. 10.1111/j.1601-0825.2005.01059.x, 15888106.
26. Noguchi K, Shitashige M, Endo H, Kondo H, Ishikawa I. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts. J Periodontal Res 2002, 37:29-36. 10.1034/j.1600-0765.2002.00641.x, 11842936.
27. Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007, 9:R75. 10.1186/ar2273, 2206385, 17683641.
28. Sato T, Konomi K, Fujii R, Aono H, Aratani S, Yagishita N, Araya N, Yudoh K, Beppu M, Yamano Y, Nishioka K, Nakajima T. Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Ann Rheum Dis 2011, 70:221-226. 10.1136/ard.2009.118620, 20870807, 20870807.
29. Rashad S, Low F, Revell P, Hemingway A, Rainsford K, Walker F. Effect of non-steroidal anti-inflammatory drugs on course of osteoarthritis. Lancet 1989, 2:1149.
30. Reijman M, Bierma-Zeinstra SM, Pols HA, Koes BW, Stricker BH, Hazes JM. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum 2005, 52:3137-3142. 10.1002/art.21357, 16200593.
31. Shirai T, Kobayashi M, Nishitani K, Satake T, Kuroki H, Nakagawa Y, Nakamura T. Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res 2011, 29:1572-7. 10.1002/jor.21394, 21462250.
32. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543. 10.2741/1817, 16146751.
33. Nishitani K, Ito H, Hiramitsu T, Tsutsumi R, Tanida S, Kitaori T, Yoshitomi H, Kobayashi M, Nakamura T. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J Cell Biochem 2010, 109:425-433. 19998410, 19998410.
34. Pillinger MH, Rosenthal PB, Tolani SN, Apsel B, Dinsell V, Greenberg J, Chan ES, Gomez PF, Abramson SB. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 2003, 171:6080-6089.
35. Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques C. Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol 2010, 185:6244-6252. 10.4049/jimmunol.0903315, 20943996, 20943996.
36. Clark CA, Li TF, Kim KO, Drissi H, Zuscik MJ, Zhang X, O'Keefe RJ. Prostaglandin E2 inhibits BMP signaling and delays chondrocyte maturation. J Orthop Res 2009, 27:785-792. 10.1002/jor.20805, 2737521, 19023895.
37. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002, 46:2648-2657. 10.1002/art.10531, 12384923.
38. Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004, 50:131-141. 10.1002/art.11433, 14730609.
39. Klatt AR, Paul-Klausch B, Klinger G, Kuhn G, Renno JH, Banerjee M, Malchau G, Wielckens K. A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res 2009, 27:65-70. 10.1002/jor.20716, 18655132.